What is he best known for?
The fields of study he is best known for:
Cell biology, Apoptosis, Edelfosine, Fas receptor and Programmed cell death are his primary areas of study.
His work on Intracellular as part of general Cell biology study is frequently connected to Munc-18, therefore bridging the gap between diverse disciplines of science and establishing a new relationship between them.
His Apoptosis research is included under the broader classification of Biochemistry.
His Edelfosine research is multidisciplinary, relying on both Cancer cell, Lipid raft, Cell killing and Cell membrane.
His research on Fas receptor often connects related areas such as Fas ligand.
He has included themes like Cell culture and Survivin in his Programmed cell death study.
His most cited work include:
- Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) (4170 citations)
- Guidelines for the use and interpretation of assays for monitoring autophagy (3242 citations)
- Microtubules, microtubule-interfering agents and apoptosis. (407 citations)
What are the main themes of his work throughout his whole career to date?
Faustino Mollinedo spends much of his time researching Cell biology, Edelfosine, Apoptosis, Biochemistry and Molecular biology.
As part of his studies on Cell biology, Faustino Mollinedo often connects relevant subjects like Syntaxin 3.
His Edelfosine research incorporates elements of Endoplasmic reticulum, Pharmacology, In vivo and Ether lipid.
His Apoptosis research includes elements of Cancer cell, Jurkat cells and Cancer research.
His Biochemistry study combines topics in areas such as Ether and Cell culture.
The Programmed cell death study combines topics in areas such as Autophagy and Cytochrome c.
He most often published in these fields:
- Cell biology (40.91%)
- Edelfosine (34.30%)
- Apoptosis (33.88%)
What were the highlights of his more recent work (between 2012-2021)?
- Edelfosine (34.30%)
- Cell biology (40.91%)
- Apoptosis (33.88%)
In recent papers he was focusing on the following fields of study:
Faustino Mollinedo mainly investigates Edelfosine, Cell biology, Apoptosis, Lipid raft and Biochemistry.
His studies in Edelfosine integrate themes in fields like Cancer cell, Protein kinase B, Endoplasmic reticulum and Pharmacology.
A large part of his Apoptosis studies is devoted to Programmed cell death.
His Programmed cell death research includes themes of Autophagy, Chaperone-mediated autophagy, Computational biology and Autolysosome.
His studies deal with areas such as Sequestosome 1, BECN1, Autophagosome and Physiology as well as Chaperone-mediated autophagy.
His Autolysosome research is multidisciplinary, incorporating perspectives in MAP1LC3B and Multicellular organism.
Between 2012 and 2021, his most popular works were:
- Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) (4170 citations)
- Lipid rafts as major platforms for signaling regulation in cancer (166 citations)
- Lipid raft-mediated Akt signaling as a therapeutic target in mantle cell lymphoma (58 citations)
In his most recent research, the most cited papers focused on:
His primary areas of study are Edelfosine, Cell biology, Lipid raft, Programmed cell death and Signal transduction.
His research in Edelfosine intersects with topics in Apoptosis and Immunology.
Faustino Mollinedo has researched Cell biology in several fields, including Cell and Internalization.
His study explores the link between Lipid raft and topics such as Fas receptor that cross with problems in Cluster of differentiation, Cell migration, Ether, Ion channel and Alkyl.
The various areas that Faustino Mollinedo examines in his Programmed cell death study include Autophagy, Chaperone-mediated autophagy, Oxidative stress, Autolysosome and Computational biology.
His study in Autolysosome is interdisciplinary in nature, drawing from both MAP1LC3B, Sequestosome 1 and BECN1.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
